Slideshow Image 1 Slideshow Image 2 Slideshow Image 3

Welcome address

EGKS Annual Meeting November 27 – 29, 2009
Moscow Gamma Knife Center and
Burdenko Neurosurgical Institute
Moscow, Russia

Dear Colleagues and friends!

On behalf of the European Gamma Knife Society, it is a great pleasure for me to invite you to the Annual Meeting in Moscow on November 27-29, 2009.

It is particularly exciting that the meeting is taking place in Moscow at the N.N.Burdenko Institute of Neurosurgery which has a long-standing tradition in neuroscience with close collaboration between basic scientists and clinicians.

We know that the risk for complications in Gamma Knife Surgery is very low, however, we would like to address the issue in a systematic fashion and have devoted the current meeting to strategies to avoid adverse radiation effects. Please submit abstracts to the following e-mail address:

We are certain that your visit to beautiful Moscow, with its interesting and long history, will be a fascinating experience for you. 

Sincerely yours,

Andrey Golanov

M.D., Professor

Head of Radiosurgery and Radiotherapy Department

Moscow Gamma Knife Center

Burdenko Neurosurgical Institute



Welcome address of the EKGS President

Dear Friends!

The topic of this year’s European Gamma Knife Society meeting in Moscow will be the discussion of adverse effects after Gamma Knife Radiosurgery. We hope that this meeting will contribute to collect essential information helpful to avoid adverse radiation effects.

The format of the annual European Gamma Knife Society meeting has been slightly different from “the large conferences”. We tried to emphasize the option for general discussions in order to conclude the meeting with a consensus. Hence the focus was on very few formal presentations allowing a non formal general brainstorming. This “radiosurgical think tank” has so far been quite successful with a lot of positive feedback.

The analysis of side effects in radiosurgery, however, may require a different approach. Since adverse radiation effects are very rare, there are very few systematic series focused around complications and even fewer systematic data are published.

Therefore we would like to invite everybody to prepare and submit even single cases or small series with adverse effects if the cases are considered of common interest. The thorough analysis even of single cases of complications can be extremely valuable for all attending colleagues, since generally these reports may not find their way into all available publications and are rarely analysed in depth. For this part of the meeting everybody is highly welcome to submit abstracts. Again the ideal approach would be to conclude the meeting with well defined open questions or with clear answers.

Even this time a few colleagues will be invited to speak about their pitfalls and complications in large series of AVM, meningiomas and metastases.

We are looking forward to meeting you again.

With best regards,

Bodo Lippitz
President EGKS